Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NIP7 pseudogene 3 (NIP7P3) is a human genomic sequence annotated as a pseudogene homologous to the NIP7 gene, a well-characterized ribosome assembly factor. Pseudogenes like NIP7P3 are generally nonfunctional remnants of protein-coding genes that have lost their protein-coding ability through mutations. There is no evidence that NIP7P3 encodes a protein or functions as a therapeutic target. As a typical pseudogene, it is not associated with disease, therapeutic modulation, or molecular interaction beyond rare potential regulatory roles seen in other pseudogenes[5][2][6]. Any search for a functional or druggable molecule under the "NIP7P3"/"NIP7 pseudogene 3" designation is likely incorrect or reflects a misannotation, as this locus does not produce the NIP7 protein nor is it a classic therapeutic target. All known biological and disease associations belong to the parent, protein-coding gene NIP7, not the pseudogene form[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NIP7 pseudogene 3 (NIP7P3).